What are peptide bioregulators like Ovagen?

They are short peptides developed in Russian research that are proposed to act on specific tissues by influencing gene expression, with Ovagen associated with liver and digestive support.

Is the evidence for Ovagen strong?

Evidence is limited and largely from the originating research group, so Ovagen remains an experimental research compound without robust independent clinical validation.

Is Ovagen approved for human use?

No. It is an unapproved research compound and should only be handled in laboratory research contexts.

← All peptides

Longevity & Anti-aging

Immune

Research Chemical

Ovagen

Also known as: Ovagen

Ovagen is a short synthetic bioregulator peptide studied for supporting liver function and protein synthesis. It belongs to the Khavinson family of tissue-specific peptide bioregulators.

Mechanism of Action

Ovagen is a short peptide bioregulator from the Khavinson class hypothesized to act as a gene-regulating signaling molecule with tissue tropism for the liver and digestive system. Such peptides are proposed to enter cells and interact with DNA promoter regions to normalize tissue-specific gene expression and protein synthesis. In the liver this is studied as support for hepatocyte function, detoxification capacity, and restoration of normal regenerative activity. The broader bioregulator hypothesis frames these peptides as restoring age- or stress-disrupted cellular homeostasis rather than acting as conventional drugs.

Half-life: Short, on the order of minutes to a few hours for short peptides
Administration Routes: subcutaneous
Research Status: Research Chemical